Michel Bracké will join the board of Directors in Karessa AB, a spin off company from FFT Medical with a focus on developing products for sexual disfunctioning.
Karessa AB is planning to list on Nasdaq First North during Q1 2015
Michel Bracké will join the board of Directors in Karessa AB, a spin off company from FFT Medical with a focus on developing products for sexual disfunctioning.
Karessa AB is planning to list on Nasdaq First North during Q1 2015